Premium
Identification of Physiological and Toxic Conformations in Aβ42 Aggregates
Author(s) -
Masuda Yuichi,
Uemura Satoko,
Ohashi Ryutaro,
Nakanishi Azusa,
Takegoshi K.,
Shimizu Takahiko,
Shirasawa Takuji,
Irie Kazuhiro
Publication year - 2009
Publication title -
chembiochem
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.05
H-Index - 126
eISSN - 1439-7633
pISSN - 1439-4227
DOI - 10.1002/cbic.200800411
Subject(s) - conformational isomerism , cerebral amyloid angiopathy , chemistry , neurotoxicity , stereochemistry , pathogenesis , amyloid (mycology) , turn (biochemistry) , protein structure , biochemistry , biology , molecule , medicine , toxicity , disease , pathology , organic chemistry , immunology , dementia , inorganic chemistry
Aggregation of the 42‐residue amyloid β‐protein (Aβ42) plays a crucial role in the pathogenesis of Alzheimer's disease (AD). Despite numerous structural studies on Aβ aggregates, the relationship between tertiary structure and toxicity remains unclear. Our proline scanning and solid‐state NMR studies suggested that aggregates both of wild‐type Aβ42 and of E22K‐Aβ42 (one of the mutants related to cerebral amyloid angiopathy) contain two conformers: a major one with a turn at positions 25 and 26, and a minor one with a turn at positions 22 and 23. To identify the toxic conformer, the derivative Aβ42‐lactam(22K–23E), in which the side chains at positions 22 and 23 were covalently linked, was synthesized as a minor conformer surrogate, along with Aβ42‐lactam(25K–26E) as a major conformer surrogate. The Aβ42‐lactam(22K–23E) showed stronger aggregation, neurotoxicity, radical generation, and oligomerization than wild‐type Aβ42, whereas in Aβ42‐lactam(25K–26E) were weak. The transition from the physiological conformation with a turn at positions 25 and 26 to the toxic conformation with a turn at positions 22 and 23 might be a key event in the pathogenesis of AD.